Ten-year experiences on initial genetic examination in childhood acute lymphoblastic leukaemia in Hungary (1993-2002). Technical approaches and clinical implementation

Pathology and Oncology Research

Volumn 17, Issue 1, 2011, Pages 81-90

  Olah, Eva ^a   Balogh, Erzsebet ^a   Pajor, Laszlo ^b   Jakab, Zsuzsanna ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

ALL; Childhood; Chromosome aberration; FISH; Prognostic factor

Indexed keywords

ABELSON KINASE; BREAKPOINT CLUSTER REGION PROTEIN; GENOMIC DNA; MIXED LINEAGE LEUKEMIA PROTEIN; PREDNISONE; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; B CELL LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ANALYSIS; CONGENITAL DISORDER; CONTROLLED STUDY; DIPLOIDY; DNA DETERMINATION; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUNGARY; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; OVERALL SURVIVAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TETRAPLOIDY; THERAPY DELAY;

ADOLESCENT; ALGORITHMS; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FEMALE; FLOW CYTOMETRY; GENETIC TESTING; HUMANS; HUNGARY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 79952698647     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9286-2     Document Type: Article

References (34)

1. Anastasi J (1993) in situ hybridization in leukemia. Applications in diagnosis, subclassification, and monitoring the response to therapy. Ann N Y Acad Sci 677:214-224
2. Andreasson P, Hoglund M, Bekassy AN, Garwicz S, Heldrup J, Mitelman F, Johansson B (2000) Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukaemias. Eur J Haematol 65(1):40-51 (Pubitemid 30432019)
3. Armstrong SA, Look AT (2005) Molecular genetics of acute lymphoblastic leukaemia. J Clin Oncol 23(26):6306-6315 (Pubitemid 46218840)
4. Berger A, Strehl S, Hekele A, Ambros PF, Haas OA, Gadner H (1994) Interphase cytogenetic study of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 23(5):413-421 (Pubitemid 24296698)
5. Chessels JM, Bailey C, Richards SM (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Lancet 345:143
6. Chessels JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM (1997) Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol 99(1):3-100
7. Gray JW, Kallioniemi A, Kallioniemi O, Pallavicini M, Waldman F, Pinkel D (1992) Molecular cytogenetics: diagnosis and prognostic assessment. Curr Opin Biotechnol 3(6):623-631
8. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3(9):639-649 (Pubitemid 37328819)
9. Harbott J, Ritterbach J, Ludwig WD, Bartram CR, Reiter A, Lampert F (1993) Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukaemia: experience of the BFM trials. Recent Results Cancer Res 131:123-132
10. Heim S, Mitelman F (1992) Cytogenetic analysis in the diagnosis of acute leukaemia. Cancer 70(6 Suppl):1701-1709
11. Huh YO, Andreeff M (1994) Flow cytometry. Clinical and research applications in haematologic malignancies. Hematol Oncol Clin North Am 8(4):703-723
12. ISCN (1995) An international system for human cytogenetic nomenclature. Karger, Basel
13. Johansson B, Mertens F, Mitelman F (2004) Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukaemia. Ann Med 36(7):492-503 (Pubitemid 39490959)
14. Kersey JH (1997) Fifty years of studies of the biology and therapy of childhood leukaemia. Blood 90(11):4243-4251
15. Márkász L, Kis LL, Stuber G, Flaberg E, Otvos R, Eksborg S, Skribek H, Olah E, Szekely L (2007) Hodgkin-lymhoma-derived cells show high sensitivity to dactinomycin and paclitaxel. Leuk Lymphoma 48(9):1835-1845 (Pubitemid 47386720)
16. Márkász L, Stuber G, Flaberg E, Gustafsson Jernberg A, Eksborg S, Oláh E, Skribek H, Székely L (2006) Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B cells. BMC Cancer 6(1):265
17. Márkász L, Stuber G, Vanherberghen B, Flaberg E, Oláh É, Carbone E, Eksborg S, Klein E, Skribek H, Székely L (2007) Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. Mol Cancer Ther 6:644-654
18. Márkász L, Hajas G, Kiss A, Lontay B, Rajnavölgyi É, Erdocombining double acute accentdi F, Oláh É (2007) Granulocyte colony stimulating factor increases drug resistance to daunorubicin and induces proliferation of leukaemic blast cells. Pathol Oncol Res (in press)
19. Mitelman F (1986) Geographic heterogeneity of chromosome aberrations in haematologic disorders. Cancer Genet Cytogenet 20 (3-4):203-208
20. Mitelman F, Heim S (1992) Quantitative acute leukaemia cytogenetics. Genes Chromosomes Cancer 5(1):57-66
21. Moricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M (2005) Prognostic impact of age in children and adolescents with acute lymphoblastic leukaemia: data from the trials ALL-BFM 86, 90, and 95. Klin Padiatr 6:310-320 (Pubitemid 41746112)
22. Pinkel D (1987) Curing children of leukaemia. Cancer 59 (10):1683-1691
23. Pinkel D (1989) Species-specific therapy of acute lymphoid leukaemia. Haematol Blood Transfus 32:27-36
24. Pui CH, Crist WM (1992) Cytogenetic abnormalities in childhood acute lymphoblastic leukaemia correlates with clinical features and treatment outcome. Leuk Lymphoma 7(4):259-274
25. Pui CH, Evans WE (1998) Acute lymphoblastic leukaemia. N Engl J Med 339:605-615
26. Raimondi SC (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukaemia. Blood 81(9):2237-2251
27. Ritterbach J, Hiddemann W, Beck JD, Schrappe M, Janka-Schaub G, Ludwig WD, Harbott J, Lampert F (1998) Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukaemia (ALL) using fluorescence in situ hybridization (FISH). Leukaemia 12(3):427-433
28. Rowley JD (1999) The role of chromosome translocations in leukaemogenesis. Semin Hematol 4(Suppl 7):59-72
29. Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G, Janka-Schaub GE, Kamps W, Masera G, Sallan S, Tsuchida M, Vilmer E (2000) Long-term results of large prospective trials in childhood acute lymphoblastic leukaemia. Leukaemia 12:2193-2194 (Pubitemid 32043589)
30. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, Gadner H, Odenwald E, Riehm H (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt- Munster. Leukaemia 12:2205-2222 (Pubitemid 32042262)
31. Schuler D (1999) Systemizing childhood cancer care in Hungary: twenty-five years of progress. Med Pediatr Oncol 32(1):68-70
32. Secker-Walker LM (1990) Prognostic and biological importance of chromosome findings in acute lymphoblastic leukaemia. Cancer Genet Cytogenet 49(1):1-13
33. Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M et al (1992) Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukaemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10(4):606-613
34. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR (2002) Classification, subtype discovery, and prediction of outcome in paediatric acute lymphoblastic leukaemia by gene expression profiling. Cancer Cell 2:133-143 (Pubitemid 41039160)